Brief: Westleaf Closes Partnership In Cannabis Derivative Product Manufacturing And Formulation
June 4 (Reuters) - Westleaf Inc WL.V :
* WESTLEAF CLOSES EXCLUSIVE PARTNERSHIP WITH AN INDUSTRY
LEADER IN
CANNABIS DERIVATIVE PRODUCT MANUFACTURING AND FORMULATION
* WESTLEAF INC - WESTLEAF AND XABIS FINALIZE AGREEMENT FOR
EXCLUSIVE CANADIAN ENGAGEMENT
* WESTLEAF INC - ITS SUBSIDIARY, WESTLEAF LABS LP, HAS
ENTERED
INTO A DEFINITIVE AGREEMENT WITH A SUBSIDIARY OF XABIS INC
* WESTLEAF INC - XABIS WILL PROVIDE TECHNICAL EXPERTISE TO
COMPANY'S CALGARY-BASED EXTRACTION, PROCESSING AND MANUFACTURING
FACILITY
Source text for Eikon: ID:nPn3mzFt6a
Further company coverage: WL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Decibel Cannabis
See all newsBrief: Decibel Comments On Tender Offer By Ewing Morris For Up To 6.8% Of Common Shares At $1.91 Per Share
Brief: Decibel Accelerates Uk Positioning With Launch Of Its General Admission And Standard Issue Brands In Partnership With Hilltop Leaf
Canada's Decibel Cannabis Q2 revenue rises on international sales growth, lifts FY outlook
Canada Research Roundup: Agnico Eagle Mines, Hudbay Minerals, Lundin Mining
Brief: Decibel Reports First Quarter 2026 Results Quarterly Revenue Grows 41% YoY To $30 Million